Advanced search

Instruments

	Name		Stock exchange	Average volume	Price	Type
	JABAL OMAR DEVELOPMENT COMPANY	4250	Saudi Arabian S.E.	2,548,031	27 SAR	Stock

News (314)

Intel : Submission of Matters to a Vote of Security Holders - Form 8-K	May. 09	PU
Allurion Reports Third Quarter 2023 Financial Results and Provides Business Update	Nov. 13	BU
Allurion Debuts as a Publicly Traded Company on the NYSE	23-08-01	BU
Compute Health Acquisition Corp. Stockholders Approve Business Combination with Allurion	23-07-28	BU
Compute Health Acquisition Corp. Warrant Holders Hold Special Meeting	23-07-26	BU
Allurion Announces New Additions to Board of Directors and Executive Leadership Team	23-07-25	BU
Allurion Technologies, Inc. and Compute Health Acquisition Corp. Remind Stockholders to Vote in Favor of Proposed Business Combination	23-07-24	BU
Compute Health Acquisition : Allurion Technologies, Inc. and Compute Health Acquisition Corp. Announce Updated Terms to Warrant Agreement Amendment - Form 8-K	23-07-24	PU
Intel : Management Change - Form 8-K	23-05-17	PU
INTEL CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	23-05-17	AQ
Allurion, a Global Leader in Weight Loss Technology, to Become Publicly Listed Through Business Combination With Compute Health Acquisition Corp.	23-02-09	BU
Allurion Technologies Inc. announced that it expects to receive $37.922333 million in funding from RTW Investments, LP	23-02-08	CI
Global markets live: GE, J&J, Verizon, Lockheed Martin, Halliburton...	23-01-24
Is the Fed losing its grip on investors?	23-01-24
Intel Chairman Omar Ishrak steps down	23-01-23	RE
Intel Appoints Frank Yeary New Independent Chair of Board	23-01-23	DJ
Intel names Frank Yeary new independent chair	23-01-23	RE
Intel Board of Directors Appoints Frank D. Yeary as New Independent Chair	23-01-23	BU
Intel Corporation Announces Changes to its Independent Chair	23-01-23	CI
Intel Elects Barbara G. Novick to Board of Directors	22-11-22	BU
Intel : BlackRock co-founder brings extensive expertise in unlocking stockholder value, accelerating transformations - Form 8-K	22-11-22	PU
Intel Elects Lip-Bu Tan to Its Board of Directors. Read more here.	22-08-12	AQ
Intel : Elects Lip-Bu Tan to its Board of Directors - Form 8-K	22-08-11	PU
Intel Elects Lip-Bu Tan to Its Board of Directors	22-08-11	BU
AMGEN INC : Submission of Matters to a Vote of Security Holders (form 8-K)	22-05-18	AQ
INTEL CORP : Change in Directors or Principal Officers, Submission of Matters to a Vote of Security Holders (form 8-K)	22-05-16	AQ
Biofourmis Receives Significant Growth Investment from General Atlantic to Propel Company to Unicorn Status	22-04-26	PR
Intel : Annual Report (Form 10-K)	22-01-27	PU
AMGEN : APPOINTS S. OMAR ISHRAK TO BOARD OF DIRECTORS (Form 8-K)	21-07-30	PU
AMGEN INC : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	21-07-30	AQ
Amgen Announces Appointment of S. Omar Ishrak to its Board of Directors	21-07-29	CI
Intel : The dean of engineering and applied science at Princeton University will become an (Form 8-K)	21-07-19	PU
Intel : Elects Andrea Goldsmith to Board of Directors	21-07-19	BU
Blackstone : Life Sciences Expands Team of Biopharmaceutical, Medical Technology, and Diagnostics Experts with Appointments of Dr. Olivier Brandicourt, Dr. Omar Ishrak, Dr. Francois Nader, and Kim Popovits as Senior Advisors	21-05-24	BU
INTEL CORP : Submission of Matters to a Vote of Security Holders (form 8-K)	21-05-19	AQ
Transcript : Intel Corporation - Shareholder/Analyst Call	21-05-13
Medtronic : Foundation and Children's Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries	21-04-07	PR
The Medtronic Foundation and Children's Heartlink Focus New Partnership on Health Equity for 10,000 Children and 10,000 Health Workers in Underserved Countries	21-04-07	CI
Compute Health Acquisition Corp. : Announces the Separate Trading of Its Class A Common Stock and Redeemable Warrants Commencing March 29, 2021	21-03-26	BU
Intel : Annual Report	21-03-11	PU
COME HEAL : CORRECTING and REPLACING Compute Health Acquisition Corp. Announces Full Exercise of Over-Allotment Option and Closing of $862,500,000 Initial Public Offering	21-02-09	BU
Transcript : Intel Corporation, Q4 2020 Earnings Call, Jan 21, 2021	21-01-21
Intel : 2020 Q4 Earnings Releases	21-01-21	PU
Dr. Omar Ishrak elected to Cargill Board of Directors	21-01-21	PR
Intel : Ousts Chief Executive Bob Swan -- 5th Update	21-01-13	DJ

1234NextSee all

Companies (1)

JABAL OMAR DEVELOPMENT COMPANY 8 342 M $

Jabal Omar Development Co SJSC is a Saudi Arabia-based real estate development company. The Companyâs main activity is to own Jabal Omar area adjacent to the western side of the Holy Mosque Square and develop it into plots of land to manage, invest, sel ...

Insiders

Omar Ishrak

Omar Syed Ishrak is the founder of Compute Health Acquisition Corp.
(founded in 2020) where he held the title of Chairman.
He currently holds the position of Chairman & Chief Executive Officer at Medtronic Trading NL BV.
Additionally, he is the Chairman at Biofourmis, Inc. (since 2022), Co-Chairman at Allurion Technologies, Inc. (since 2023), Independent Director at Amgen, Inc. (since 2021), Independent Director at Intel Corp.
(since 2017), Director at Cargill, Inc. (since 2021), Director at Insightec Ltd.
(since 2022), and Trustee at Asia Society (since 2021).
Dr. Ishrak has also held former positions including Chairman & Chief Executive Officer at Medtronic, Inc. (2011-2020), President & Chief Executive Officer at Health Care Systems, Inc., President & Chief Executive Officer at Clinical Systems, Inc., President & Chief Executive Officer at GE Healthcare, Inc. (2009-2011), President & Chief Executive Officer at GE Healthcare Clinical Systems (Wisconsin) (2005-2008), and Executive Chairman at Medtronic Ltd.
and Medtronic Plc (2011-2020).
He has also served as a Senior Vice President at GE Aerospace, a Trustee at Minnesota Public Radio, and General Manager at Ultrasound, Inc. Dr. Ishrak received his undergraduate and doctorate degrees from King's College London.

Mr. Omar Abu Omar is a President-Maritime & Operations at Gulf Navigation Holding PJSC.
Mr. Abu Omar was previously employed as a Manager-Area & Regional Development by DNV GL Ltd.
and a Chief Operating Officer by Emirates Classification Society.
He received his graduate degree from Norwegian University of Science & Technology.

Aliff Omar Mohamad Omar

Aliff Omar is a Senior Director of Investment at Ekuinas.
He joined the company as a Director, Investment in July 2017 covering the energy and consumer space.
He is a member of the Investment Committee and Management Committee.
Aliff carries with him over 14 years’ experience in corporate advisory and deal-making.
Prior to joining Ekuinas, Aliff was a Director of Investment Banking at UBS AG.
He led a number of M&A and Capital Markets transactions in Malaysia and across Southeast Asia, advising corporates within the energy, financial institutions, infrastructure & utility and real estate sectors.
Before UBS, Aliff was with the Regional M&A team of CIMB Investment Bank and the Investment Banking Division of Maybank Investment Bank.
Aliff graduated with a BSc in Industrial Engineering & Management Sciences (Cum Laude) with a second major in Economics from Northwestern University and an MPhil in Finance from University of Cambridge.

Omar Farouq Omar Abdullah Al

Omri Omar Ahmed Omar Al

Omar Manejwala

Omar Manejwala is currently the Chief Medical Officer at DarioHealth Corp.
He previously worked as the Medical Director at Hazelden Foundation, Inc. and as the Associate Medical Director at The Farley Center.
He also served as the Chief Medical Officer at Ontrak, Inc. Dr. Manejwala holds a doctorate from the University of Maryland School of Medicine and an MBA from the University of Virginia Darden School of Business.

No results for this search